Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVER: Fulvestrant, Lapatinib, and AI in Metastatic Breast Cancer
NCT02394496Phase 3Unknown
- Sponsor
- Consorzio Oncotech
- Start
- Nov 2007
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by Consorzio Oncotech. Status: unknown.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02394496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394496.